So the short version is that 5.5% is a good result by the standard a laboratory applies, and a slightly above-target one if you are optimizing rather than screening. The rest of this page covers what sits behind the number, what can pull a single reading up or down, why 5.4% and 5.5% are not meaningfully different, and which other results make a value in this range easier to read.
It measures the percentage of your hemoglobin that has glucose attached to it. Glucose binds to hemoglobin inside red blood cells at a rate that follows how much glucose surrounds them, and that binding does not come undone, so the percentage accumulates across the lifespan of each cell. Because red cells live for a few months, the result reflects average glucose exposure over roughly the last two to three months, weighted towards the most recent weeks. Results are reported on a globally standardized scale, which is what allows a value measured in one laboratory to be compared with one measured in another 1. The full detail on the marker, how the sample is collected and how its reference ranges are set sits on the Hemoglobin A1C page.
Below all of them. A 5.5% result falls under every diabetes-related threshold in routine use, and inside the standard reference interval, in its upper half. The number that matters most here is 5.7%, the point at which laboratories start reporting a result in the prediabetes category, and 5.5% sits two tenths of a percentage point underneath it. A value of 6.5% and above is the level at which the test is used to diagnose diabetes, a role it was able to take on once method standardization made values comparable between laboratories 2.
| Where the value falls | A1c | How it is usually regarded |
|---|---|---|
| FitScript optimal range | 4.6 to 5.3% | FitScript's optimization target |
| Standard lab reference range | 4 to 5.7% | The typical reported normal interval |
| A result of 5.5% | 5.5% | Inside the normal interval, above the optimal target |
| Prediabetes category | 5.7 to 6.4% | Labs regard this band as above the normal interval |
| Diabetes category | 6.5% and above | The level used for diagnosis 2 |
These are typical lab reference ranges, and they vary by laboratory, age and sex, so read your own report against the interval printed beside your result. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and the two answer different questions. A single value, wherever it falls, is not a diagnosis of anything. It is one measurement of one process, and a clinician reads it alongside your history, your symptoms and the rest of your panel.
No, and that gap is the whole reason a 5.5% can feel ambiguous. A standard reference interval describes the spread of results found across a tested population, which includes plenty of people whose glucose handling is drifting but has not yet crossed a reporting threshold. An optimal range describes where a marker tends to sit when the underlying system is working comfortably. A result can be normal by the first definition and above target by the second at the same time, which is exactly what 5.5% is.
It also helps to remember that metabolic risk does not switch on at a threshold. The cut-offs are administrative lines drawn across a continuous variable, useful for deciding who gets investigated and unhelpful for pretending that 5.69% and 5.71% describe different people. Research suggests that, in people with prediabetes, higher A1c values together with abdominal obesity predict later progression to diabetes and to atherosclerotic cardiovascular disease, which is consistent with risk rising gradually rather than appearing at a line 3.
The practical reading of a 5.5% is therefore unremarkable but not invisible. Nothing about it calls for alarm. It does make the direction of travel worth knowing, because the useful information is less in today's value and more in whether the next one sits above or below it.
They look like an average, and averages hide their own shape. Every red cell in circulation carries a record of the glucose it has been bathed in since it was made, and the test pools that record across cells of every age. A cell near the end of its life contributes months of exposure. A cell made last week contributes almost nothing yet. That is why the result leans towards recent weeks without ignoring what came before, and why a change you made ten days ago will barely register.
This also means two people can both report 5.5% and have lived very different days. One may run a steady glucose that rarely moves far in either direction. The other may spike high after meals and dip low between them, with the peaks and troughs cancelling out into the same average. Some laboratories print an estimated average glucose next to the A1c, which is a mathematical conversion of the same number and not a second, independent measurement.
For anyone reading a result in the normal range, this is the main limitation to hold in mind. The value tells you where the centre of gravity of your glucose has been. It says nothing about the swings around that centre, nothing about what happens two hours after your usual breakfast, and nothing about whether your insulin is working hard to keep the average where it is.
Because the two tests fail in opposite directions, and together they cover more ground than either alone. Fasting glucose is a single snapshot taken in a single state, sensitive to what you ate last night, how you slept and how stressed the morning was. A1c is an average that smooths all of that away but cannot show you a single moment. Reading them side by side is how you find out whether a normal average is built on steady days or on a see-saw.
Studies indicate that A1c alone does not capture glycemic variability or episodes of low glucose, which is why other measures are used alongside it when a fuller picture is needed 4. Alternative approaches, including markers that cover a shorter window and continuous glucose monitoring, exist precisely because the three month average answers only part of the question 5.
Discordance between the two is common and informative rather than alarming. A 5.5% with a comfortably normal fasting glucose is a coherent, reassuring pair. A 5.5% with a fasting glucose creeping towards the top of its reference interval is a pair worth a conversation, because it suggests the average is being held down by good stretches rather than by consistently easy glucose handling. The reverse pattern, a higher A1c with a low fasting glucose, more often points towards something affecting red cells than towards glucose itself.
Anything that changes how long your red blood cells live, or that interferes with the measurement itself. Because the test infers glucose exposure from hemoglobin carried by cells of an assumed age, anything that shortens or lengthens that lifespan shifts the result away from the glucose average it is meant to represent. Research suggests that conditions altering red cell survival, inherited hemoglobin variants and certain assay interferences are recognised pitfalls of the test, and that they can push a value in either direction 5.
| What is going on | Likely effect on the reading |
|---|---|
| Shortened red cell survival, including hemolysis or recent significant blood loss | Reads lower than the true glucose average |
| Recent blood transfusion | Unreliable, because donor cells carry their own history |
| Iron deficiency anemia | May read higher than the true average |
| Early recovery from iron deficiency, with a wave of new red cells | May read lower than the true average |
| Some inherited hemoglobin variants | Up or down, depending on the method used |
| Advanced kidney disease | Often reads lower |
| Pregnancy | Often reads lower, with the shift changing across trimesters |
| Absent or non-functioning spleen | May read higher, as cells survive longer |
The measurement side matters too. Assay standardization has made results far more consistent between laboratories than they once were, which is part of why the test became usable for diagnosis at all 1. It has not made every method identical in the face of an unusual hemoglobin, and a laboratory will sometimes note that a variant was detected. None of this is a reason to discount an unexpected result. It is a reason to ask your clinician whether a red cell issue, rather than glucose, is the better explanation, and whether a complete blood count belongs alongside the next test.
Not in any way you should act on. One tenth of a percentage point sits within the combined noise of the measurement and of ordinary biology, which is why a single-step move between two reports rarely tells you anything about what your metabolism did. Treating 5.4% as a win and 5.5% as a setback is reading the error bars rather than the signal.
The standardized reporting scale has narrowed the differences between methods considerably 1, but narrowing is not elimination, and two samples from the same person on the same morning will not always return an identical figure. Day to day biological variation adds its own small spread on top of that. Research suggests that the size of the change between successive measurements, rather than any single value, is the sensible basis for deciding how often the test should be repeated 6.
The useful habit is to watch the trend across several tests taken under similar conditions, ideally at the same laboratory, and to treat only a sustained direction as real. A value that moves from 5.4% to 5.5% to 5.4% is a flat line with noise on it. A value that moves from 5.2% to 5.5% to 5.8% across a year is a trend, and that is the pattern worth taking to a clinician while it is still early.
It suggests that, on this one marker, nothing is pressing. A 5.5% is below the band where screening normally escalates, and on its own it does not place you in any risk category. What it does not do is clear you of metabolic risk, because A1c is a single lagging average and much of what drives cardiometabolic disease shows up in other measurements first.
Body composition is the clearest example. In people with prediabetes, abdominal obesity is associated with progression to diabetes and with atherosclerotic cardiovascular disease alongside A1c itself, so waist measurement and glycation carry information that does not fully overlap 3. Two people with the same 5.5% and very different waist circumferences are not in the same position, and reading the lab value in isolation would miss that entirely.
The honest framing is that a normal A1c removes one worry rather than all of them. It does not rule out insulin working hard behind the scenes to keep glucose level, it does not describe lipids, blood pressure, liver fat or inflammation, and it does not predict where you will be in five years. That is an argument for breadth in testing rather than for anxiety about one decimal place.
Mostly the same things that shape average glucose over weeks, plus a few that have nothing to do with glucose at all. The glucose-side factors are the familiar ones. Total carbohydrate load and how refined it is, the fibre, protein and fat eaten alongside it, how often you eat, and how much of each day involves moving rather than sitting all feed into the average that the test records.
Muscle is a large part of this. Skeletal muscle is the biggest destination for glucose after a meal, and both the amount you carry and how recently you used it influence how quickly circulating glucose is cleared. A single walk after dinner changes one afternoon. A year of resistance training and daily movement changes the three month average that the test can actually see.
Short sleep, heavy alcohol, acute illness and sustained stress all raise counter-regulatory hormone output, which pushes glucose up in the short term, and a run of weeks like that will show up in the next result. Visceral fat around the abdomen matters more to glucose handling than overall body weight does, which is why waist measurement earns its place next to the scale.
Then there are the factors that move the number without moving your glucose, covered in the section above. Age, inherited hemoglobin variants, iron status, pregnancy and anything affecting red cell turnover all shift the relationship between average glucose and the reported percentage. A clinician weighs both sets of factors before concluding that a change in the number reflects a change in your metabolism.
Less often than most people expect, because the test is slow by design. Two samples taken a few weeks apart are largely reading the same population of red cells, so the second one mostly repeats the first with fresh measurement noise added. Allowing a meaningful span of time between tests is what lets a real change separate itself from variation.
Research suggests that how much the value has changed between measurements is a more rational basis for setting the retest interval than a fixed calendar schedule, with stable results justifying longer gaps and moving ones justifying closer attention 6. In practice that means a steady value in the normal range does not need frequent rechecking, while a value that has climbed across two consecutive tests is a reason to keep a closer eye on it. The interval that suits you is a clinical decision rather than a rule, and it depends on your history, your other markers and what, if anything, you have changed.
If you are deliberately working on diet, training or body composition, it is worth waiting long enough for your red cells to catch up before judging the effect. Retesting at the same laboratory, under similar conditions, also removes one source of difference between reports.
The ones that describe insulin, the ones that describe shorter time windows, and the ones that reveal whether red cells are distorting the result. A1c on its own is a narrow view of a wide system, and its value rises sharply when it is read as part of a panel. FitScript's membership covers 150+ biomarkers tested per year, with Atlas, FitScript's AI health advisor, interpreting how they sit together.
| Marker or measure | What it adds next to A1c |
|---|---|
| Fasting glucose | A point-in-time value that shows whether the average is built on steady mornings |
| Fasting insulin and insulin resistance indices | Whether normal glucose is being held normal by a rising insulin effort |
| Oral glucose tolerance test | How glucose behaves under a defined load rather than at rest |
| Continuous glucose monitoring | The shape of the day, including swings an average cannot show 5 |
| Fructosamine or glycated albumin | Glycation over a shorter window, useful when red cell issues are suspected 5 |
| Complete blood count, ferritin and iron studies | Whether anemia or iron status is skewing the percentage |
| Triglycerides and HDL cholesterol | Lipid patterns that often shift before glucose does |
| Liver enzymes | Context for fat stored in the liver |
| hs-CRP | Background inflammation sitting alongside metabolic change |
| Waist circumference | Abdominal fat, which carries information A1c does not 3 |
The point of the panel is not to accumulate numbers. It is that a 5.5% means one thing with a low fasting insulin and a trim waist, and something worth watching with a high fasting insulin, rising triglycerides and a growing waistline. The same lab value, two different stories.
Then the mismatch is the finding, and it is usually more useful than either number alone. Here is how the common combinations tend to read, with the caveat that none of them is a diagnosis and all of them belong in a conversation with a clinician who can see your full history.
A normal A1c with a fasting glucose near or above the top of its reference interval suggests the three month average is being pulled down by stretches of easy glucose handling, while mornings are running warm. It can also be a one-off, since fasting glucose responds to a poor night's sleep, a late meal or a stressful morning. Repeating the fasting glucose under better-controlled conditions, rather than repeating the A1c, is usually the faster way to find out which it was.
A move from 5.1% to 5.5% is still a normal result, but it is movement, and direction is the part of this test that carries the most information. Before reading too much into it, check that both samples came from the same laboratory and that nothing in between changed your red cell turnover. If the trend holds across a third test, it is worth discussing early, when the options under consideration are the ordinary ones around food, training, sleep and body composition.
In people with anemia, an altered red cell lifespan or an inherited hemoglobin variant, the relationship between average glucose and the reported A1c is no longer reliable, which is why these situations are listed among the recognised pitfalls of the test 5. A clinician may lean on glucose measurements directly, or on a marker covering a shorter window, to get a cleaner read. The A1c is not useless in this situation, it simply needs interpreting rather than taking at face value.
Family history does not change what a 5.5% says today, but it does change how closely the trend is worth following. The same applies in people with a history of gestational diabetes or polycystic ovary syndrome. In these situations the conversation is usually about how often to retest and what else to measure, not about the current value, which remains a normal one.
Whenever it is not the only thing you are looking at. A normal A1c in isolation rarely needs a dedicated appointment, but it is worth raising at your next review if the value has risen across consecutive tests, if your fasting glucose or fasting insulin is less tidy than the A1c suggests, if your waist has grown, or if diabetes runs in your family. It is also worth mentioning any condition or result affecting your red blood cells, since that changes how the percentage should be read.
Symptoms always outrank a reassuring number. Unusual thirst, frequent urination, unexplained weight loss, blurred vision or persistent fatigue deserve attention regardless of where your A1c sits, and are worth discussing with a clinician promptly rather than waiting for the next panel. Equally, never set aside a result your laboratory has flagged because a different marker looked fine.
If the discussion turns to anything beyond diet, training, sleep and body composition, a licensed provider evaluates whether a given option is appropriate for you, based on your full history rather than on one value. This page is educational and is not medical advice. Discuss your results, and any treatment, with a clinician or licensed provider who can see your whole picture.
If you want to go deeper, the guide on how to lower your hemoglobin a1c covers the levers that actually move a three month average, and if your next test lands a little higher, is hemoglobin a1c 5 7 bad walks through what that threshold does and does not mean.
Yes. It falls inside the typical lab reference range of 4 to 5.7% and below the 5.7% point where labs begin reporting the prediabetes category. It does sit above FitScript's optimal range of 4.6 to 5.3%, so it is normal by the lab standard and slightly above an optimization target.
No. A 5.5% result is below the 5.7% threshold that labs use to start reporting the prediabetes category, and a single value is never a diagnosis on its own. A clinician reads it alongside your fasting glucose, your history and the rest of your panel before drawing any conclusion.
Not in any way worth acting on. One tenth of a percentage point sits inside the normal variation of the measurement and of day to day biology. Watch the direction across several tests taken at the same laboratory instead, because a sustained trend carries real information and a single step does not.
Values inside the normal range can shift with eating pattern, activity, muscle mass, sleep and body composition, though part of the number is set by how long your red blood cells live. Whether lowering it further is a sensible goal for you is a question for a clinician who knows your history.
No. The test reflects glucose exposure over roughly the past two to three months, so a recent meal does not change it. If a fasting glucose, insulin or lipid panel is being drawn from the same sample, your lab may still ask you to fast for those.
Allow a few months. Because the number builds up across the lifespan of your red blood cells, a change made in the past couple of weeks barely registers. Retesting too soon mostly measures the same cells again, so give it enough time for a genuine shift to become visible.
There is no fixed pairing. One is an average over months and the other is a single morning snapshot, so they often sit differently. If your fasting glucose is near the top of its reference interval while your A1c looks fine, that mismatch is worth raising with a clinician.
Yes. In people with anemia, recent blood loss, a recent transfusion or an inherited hemoglobin variant, the reported percentage can drift away from true average glucose in either direction. A complete blood count and iron studies alongside the test help your clinician decide how to read the number.
That depends on whether it is stable and on what else is in your panel. A steady value in the normal range does not need frequent rechecking, while one that has climbed across consecutive tests deserves closer follow-up. The interval is a clinical decision rather than a fixed schedule.